# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...
B. Riley Securities analyst Ryan Pfingst maintains NuScale Power (NYSE:SMR) with a Buy and raises the price target from $8 t...
On CNBC's "Mad Money Lightning Round," Jim Cramer isn't thrilled with Palo Alto Networks, seemingly reversing h...
NuScale Power (NYSE:SMR) shares are trading down Monday. It's among several stocks that have experienced trading interrupti...